Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Explore the main factors that move a stock index, including macroeconomic data, earnings, and policy changes that influence index levels.
21,956 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Broadcom stock rallied Thursday as AI-driven demand for semiconductor hardware pushed shares higher. This article bre...
Target's Circle Deal Days is more than a promo. It could be a lever for traffic, online sales, and margins. This arti...
Bitcoin volatility remains headline news, but one historically cheap stock in gold mining delivers tangible cash flow...
Nvidia sits at the center of a rapid AI infrastructure buildout. Here’s how the stock could move by 2029, based on gr...
What could push American Express higher by 2030 and what risks loom? A practical look at growth, valuation, and strat...
Investors are expanding beyond Vanguard in March 2026 as cost, access, and tool diversity drive choice. This report h...
A freshly launched crypto-transfer feature helped push Interactive Brokers stock bumped higher by nearly 4% today. Th...
Gap and Lululemon present two starkly different investment pitches: a steady income stock with a buyback boost versus...
A sudden stock pullback creates a rare entry point for patient investors. The company combines non-discretionary serv...
Novo Nordisk isn’t in the spotlight, but its steady cash flow and strong pipeline could unlock long-term gains. This ...
Thinking about Home Depot stock? This guide breaks down three essential things know about home to help you decide if ...